Navigation Links
12 science and technology tours being held in conjunction with Pittsburgh's G20 Summit
Date:8/28/2009

PITTSBURGH The University of Pittsburgh, Carnegie Mellon University, and the University of Pittsburgh Medical Center will be hosting 12 science and technology tours Sept. 21 in conjunction with the G20 Pittsburgh Summit Sept. 24-25. These tours of cutting-edge research and development will help explain how and why the "eds and meds" sector of Pittsburgh's economy has become a powerful driver of the region's success.

The Eds-Meds program will begin at 10:30 a.m. at Soldiers and Sailors Memorial auditorium, 4141 Fifth Ave., Oakland, with remarks by Carnegie Mellon President Jared L. Cohon, Pitt Chancellor Mark A. Nordenberg, and UPMC President and CEO Jeffrey A. Romoff. Tours will begin at noon, 2 p.m., and 4 p.m.

Tour sites are: Children's Hospital of UPMC, the Peter M. Winter Institute for Simulation, Education, and Research (WISER), Biomedical Science Tower 3, McGowan Institute for Regenerative Medicine, Center for Global Health, the Sports Performance Complex, the Robotics Institute, the Entertainment Technology Center, the Pitt Green Tour, the Center for Energy, the Quality of Life Technology Center, and the Intelligent Workplace.

Tours are for summit delegates and members of the media. Media interested in attending must have a photo ID from the media outlet they represent.


'/>"/>

Contact: Morgan Kelly
mekelly@pitt.edu
412-624-4356
University of Pittsburgh
Source:Eurekalert  

Page: 1

Related medicine news :

1. Larta Institute Wins National Science Foundation (NSF) Contract
2. HerbalScience Research Identifies Key Bioactives in Nettle Extract That Inhibit Inflammation Associated with Seasonal Allergies
3. AED School Program at Its Best: Atlanta Public Schools Partnership With Cardiac Science
4. Greenberg Traurig Attorney Selected For Massachusetts Life Sciences Collaborative Task Force
5. Aging Science Leaders to Gather During Active Aging Week to Encourage Discovery in Healthy Living and Longevity
6. Online Think Tank Big Think Launches New Multimedia Web Series Exploring Some of the Most Pressing Science and Medical Issues of our Time
7. Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine(TM) For Prostate Conditions With Start-Up of Phase 2 BPH Trial
8. Family Research Council President Tony Perkins Asks: Is This What President Obama Means by Robust Conscience Protections?
9. Derma Sciences Reports Second Quarter 2009 Results
10. Human Pheromone Sciences Announces Second Quarter Results
11. HerbalScience Research Identifies Specific Bioactives In Stabilized Rice Bran Extract that Impart Anti-Inflammatory Benefits
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
12 science and technology tours being held in conjunction with Pittsburgh's G20 Summit
(Date:4/22/2017)... Freedom, PA (PRWEB) , ... April 22, 2017 ... ... healthcare experience to his role as Vice President of Sales and Business Development ... of key GPO/IDN business partner engagements, business development, and strategic planning for the ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to announce ... the 2017 London Marathon. Set to take place on April 23rd, the London Marathon has ... Schwartz will run as part of team EMPOWER, raising money for the international charity, Smile ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of ... with the 2017 Ruth Ravich Patient Advocacy Award in recognition of her ... was honored with the award at The Beryl Institute’s annual Patient Experience Conference ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/19/2017)... OAKS, Calif. , April 19, 2017 /PRNewswire/ ... industrial buildings it is developing at Conejo Spectrum ... , to Atara Biotherapeutics, Inc. , ... with severe and life-threatening diseases that have been ... on allogeneic T-cell therapies for cancer, autoimmune and ...
Breaking Medicine Technology: